Megatelmisartan 40 mg (Telmisartan)

Adult dose

For essential hypertension, Telmisartan should be taken orally at a dose of 40 mg once daily with water, regardless of meals. Depending on the patient, 20 mg once daily may be effective, and if needed, the dose may be increased to 80 mg once daily. Dose increases will show the maximum antihypertensive effect around 4 to 8 weeks after treatment initiation. For reduction of cardiovascular disease risk, it is recommended to take this medication at a dose of 80 mg once daily with water, regardless of meals. There is no known effect on the morbidity and mortality of cardiovascular diseases at doses less than 80 mg. When starting treatment for the purpose of reducing the risk of cardiovascular diseases, monitoring blood pressure is recommended, and appropriate adjustment of antihypertensive medications may be required.

This medication can pose serious risks to the fetus and neonates during pregnancy; therefore, it should be discontinued immediately if pregnancy is confirmed. Women who are pregnant or may become pregnant, as well as nursing mothers, should not use this medication. Patients with severely impaired liver function or issues with bile excretion should avoid this medication. Those with specific genetic disorders should also refrain from taking this drug. Elderly patients, patients with decreased kidney function, and patients with high serum potassium levels should use this medication with caution. Patients with heart disease or gastrointestinal disorders should also be cautious. During treatment with this medication, blood pressure, kidney function, and electrolyte levels should be monitored regularly. Serious side effects such as angioedema, hyperkalemia, and renal impairment may occur; consult a healthcare provider immediately if symptoms appear. Interactions may occur when combined with other antihypertensive drugs or specific medications, so it is essential to inform healthcare providers. This medication may cause symptoms such as hypotension, dizziness, and acute renal failure in the case of overdose; caution is advised. Safety and efficacy have not been established for children, so it is not recommended. Caution is required when driving or operating machinery due to the possibility of dizziness or fainting. Keep out of the reach of children and do not transfer the medication to another container.

Serious side effects

Hives, angioedema, anaphylactic reactions, sepsis, angioedema (including fatal outcomes), respiratory distress due to laryngeal edema, renal failure, acute renal failure, shock, loss of consciousness, liver dysfunction, jaundice, symptoms resembling anaphylaxis, respiratory distress, laryngeal edema, interstitial lung disease, fever, pneumonia, respiratory distress, severe dermatological reactions, toxic skin rashes, severe allergic reactions, severe edema, increased blood pressure, angioedema

Mild side effects

• Upper respiratory infections
• pharyngitis
• sinusitis
• urinary tract infections
• cystitis
• anemia
• thrombocytopenia
• eosinophilia
• hypersensitivity
• hyperkalemia

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is recommended to maintain a storage temperature between 1°C and 30°C. Proper storage helps to maintain the drug's effectiveness and safety.

Appearance

White oblong tablet

Package unit

30 tablets/bottle